nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2024, 12, v.47 1616-1620+1626
重酒石酸卡巴拉汀胶囊联合胞二磷胆碱治疗脑梗死后认知功能障碍的疗效观察
基金项目(Foundation): 上海市科技计划项目(22S31902289)
邮箱(Email): yfhy1229@163.com;
DOI:
发布时间: 2024-12-15
出版时间: 2024-12-15
移动端阅读
摘要:

目的 观察脑梗死后认知功能障碍患者采用重酒石酸卡巴拉汀胶囊联合胞二磷胆碱的治疗效果。方法 将2023年1月至2024年1月上海健康医学院附属崇明医院92例脑梗死后认知功能障碍患者按随机数字表法分为对照组和观察组,各46例。对照组采用胞二磷胆碱治疗,观察组于对照组基础上联合重酒石酸卡巴拉汀胶囊治疗。两组均连续治疗8周。比较两组治疗后认知功能、日常生活能力、血清神经细胞因子水平、沉默信息调节因子-1(SIRT1)/核因子-κB(NF-κB)信号通路相关指标及不良反应发生情况。结果 治疗后,观察组蒙特利尔认知评估量表(MoCA)评分、简易精神状况检查量表(MMSE)评分、Barthel指数评定量表(BI)评分、SIRT1、神经生长因子(NGF)和脑源性神经营养因子(BDNF)水平均高于对照组(P<0.05),S100蛋白、神经元特异性烯醇化酶(NSE)、NF-κB均低于对照组(P<0.05);观察组不良反应发生率同对照组比较差异无统计学意义(P>0.05)。结论 重酒石酸卡巴拉汀胶囊联合胞二磷胆碱能显著减轻脑梗死后认知功能障碍,其机制可能与调节SIRT1/NF-κB信号通路有关。

Abstract:

Objective To observe the therapeutic effect of carbalatine bitartrate capsule combined with citicoline in patients with cognitive dysfunction after cerebral infarction. Methods From January 2023 to January 2024, 92 patients with cognitive dysfunction after cerebral infarction in the hospital were divided into a control group and an observation group using the random number table method, with 46 patients in each group. The control group was treated with citicoline, while the observation group received additional rivastigmine tartrate capsules on the basis of the control group′s treatment. Both groups were treated continuously for 8 weeks. The cognitive function, daily living ability, serum neurocytokine level, silence-information regulator-1(SIRT1)/nuclear factor-κB(NF-κB) signaling pathway and the incidence of adverse reactions were compared between the 2 groups after thetreatment. Results After 8 weeks of the treatment, the Montreal Cognitive Assessment(MoCA) score, Mini-Mental State Examination(MMSE), Barthel Index(BI) score, SIRT1, nerve growth factor(NGF) and brain-derived neurotrophic factor(BDNF) levels the observation group were higher than those in the control group(P<0.05), while S100 protein, neuron-specific enolase(P>0.05), and NF-κB were lower than those in control group(P<0.05); there was no significant difference in the incidence of adverse between the observation group and the control group(P>0.05). Conclusion The combination of rivastigmine tartrate capsules and cytidine diphosphate choline can significantly alleviate cognitive impairment after cerebral infction, which may be related to the regulation of the SIRT1/NF-κB signaling pathway.

参考文献

[1] 杨丽娜,魏昌伟.卒中后认知障碍的研究进展[J].北京医学,2023,45(5):439-442.

[2] 李娜,于海芙,朱菊花.醒神通腑方联合胞二磷胆碱对急性脑梗死昏迷患者神经功能损伤的影响[J].西部中医药,2020,33(12):84-88.

[3] 万奇,邓炎尧,郝婧雯,等.重复经颅磁刺激联合胆碱酯酶抑制剂对阿尔茨海默病认知障碍的影响及机制[J].中国老年学杂志,2023,43(18):4440-4443.

[4] KADDOUMI A,DENNEY T S J R,DESHPANDE G,et al.Extra-virgin olive oil enhances the blood-brain barrier function in mild cognitive impairment:A randomized controlled trial[J].Nutrients,2022,14(23):5102.

[5] 刘慧群,葛静雅,刘畅,等.胆碱酯酶抑制剂卡巴拉汀联合高频rTMS治疗阿尔茨海默病的临床研究[J].中西医结合心脑血管病杂志,2023,21(7):1322-1326.

[6] 汪凯,董强.卒中后认知障碍管理专家共识2021[J].中国卒中杂志,2021,16(4):376-389.

[7] 孙云,沈晓星,王变荣,等.ACE-Ⅲ量表和MOCA量表在老年认知障碍诊断中的应用价值研究[J].老年医学与保健,2022,28(3):513-516.

[8] 魏霞霞,郝志梅,陈玲,等.简版CSI-D与MMSE在我国中老年人痴呆筛查中的应用效果比较研究[J].中国全科医学,2022,25(31):3866-3871.

[9] 王蒙,杨荔慧,王明霞,等.计算机化认知功能训练对轻度认知功能障碍老年人的干预效果研究[J].解放军医学院学报,2021,42(5):504-508.

[10] 邹永明,舒睿,王娜,等.老年急性缺血性脑卒中患者3个月后认知障碍相关因素分析及其预测价值[J].中华物理医学与康复杂志,2023,45(1):18-23.

[11] KOCH G,CASULA E P,BONNì S,et al.Precuneus magnetic stimulation for Alzheimer′s disease:A randomized,sham-controlled trial[J].Brain,2022,145(11):3776-3786.

[12] 吴婧,董兰真,张丽丽,等.尼麦角林联合卡巴拉汀治疗对VD患者脑微循环及免疫功能的影响[J].川北医学院学报,2024,39(3):324-327.

[13] GOTUR A J,PRASAD K,BHATIA R,et al.Rivastigmine for cognitive impairment in multiple sclerosis:a prospective randomized open label study with blinded end-point assessment[J].Neurol India,2023,71(3):514-521.

[14] SCHURAD B,KOCH C,SCHUG B,et al.Comparative bioavailability study of a novel multi-day patch formulation of rivastigmine (twice weekly) with exelon? transdermal patch (daily)- a randomized clinical trial[J].Curr Alzheimer Res,2022,19(7):541-553.

[15] 陈中华.重酒石酸卡巴拉汀胶囊联合经颅磁刺激治疗脑卒中后认知功能障碍的疗效观察[J].临床医学工程,2020,27(7):925-926.

[16] 肖锋,吴俊波.醒脑静胞二磷胆碱对脑出血患者术后疗效的影响[J].中国老年学杂志,2021,41(24):5508-5510.

[17] 林燕,王丽娟.盐酸美金刚联合重酒石酸卡巴拉汀治疗中度阿尔兹海默症患者的临床研究[J].中国临床药理学杂志,2023,39(14):2015-2019.

[18] 许朝卿,孙鑫海,舒龙,等.银杏达莫联合丁苯酞治疗缺血性脑卒中后认知功能障碍患者的临床研究[J].中国临床药理学杂志,2021,37(14):1846-1850.

[19] 王晓元,杜美玲,易梦阳,等。心房颤动患者外周血沉默信息调节因子2相关酶1/核因子κB信号通路与认知功能障碍的相关性研究[J].中国医刊,2022,57(7):738-741.

[20] 夏静,魏月,舒艳,等.银杏叶提取物片联合重酒石酸卡巴拉汀治疗阿尔茨海默病的临床研究[J].中西医结合心脑血管病杂志,2022,20(23):4355-4359.

[21] 肖欢,朱莲,冯晓荣.胞磷胆碱联合奥拉西坦治疗高血压脑出血临床效果及对炎性因子、氧化应激、NIHSS评分的影响[J].解放军医药杂志,2021,33(12):88-91.

基本信息:

中图分类号:R743.33;R749.1

引用信息:

[1]郭俊,秦云.重酒石酸卡巴拉汀胶囊联合胞二磷胆碱治疗脑梗死后认知功能障碍的疗效观察[J].新疆医科大学学报,2024,47(12):1616-1620+1626.

基金信息:

上海市科技计划项目(22S31902289)

发布时间:

2024-12-15

出版时间:

2024-12-15

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文